Can-Fite BioPharma Ltd. (TLV:CANF)
Israel · Delayed Price · Currency is ILS · Price in ILA 672.40
-29.00 (-4.13%)
Jan 30, 2026, 1:44 PM IDT
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of 17.61 million as of January 30, 2026. Its market cap has decreased by -62.40% in one year.
Market Cap
17.61M
Enterprise Value
-3.84M
Revenue
1.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
672.40
Market Cap Chart
Since November 3, 2008, Can-Fite BioPharma's market cap has decreased from 69.53M to 17.61M, a decrease of -74.68%. That is a compound annual growth rate of -7.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 17.61M | -77.59% |
| Dec 31, 2025 | 78.55M | 38.59% |
| Dec 31, 2024 | 56.68M | 77.98% |
| Dec 31, 2023 | 31.85M | -53.53% |
| Dec 29, 2022 | 68.52M | -42.86% |
| Dec 30, 2021 | 119.91M | 29.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 434.47M |
| Geffen Residence & Renewal | 261.69M |
| Matricelf | 143.84M |
| Clal Biotechnology Industries | 48.47M |
| BioLineRx | 39.16M |
| BioLight Life Sciences | 34.65M |
| Evogene | 27.76M |
| XTL Biopharmaceuticals | 25.55M |